Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index; 29 of the 35 sources its claims cite were checked for support.

Modeling the binding of diverse ligands within the Ah receptor ligand binding domain

Open access
Giani Tagliabue, Sara, Faber, Samantha C., Motta, Stefano, Denison, Michael S., Bonati, Laura · 2019 · Scientific Reports

Abstract

The Ah receptor (AhR) is a ligand-dependent transcription factor belonging to the basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) superfamily. Binding to and activation of the AhR by a variety of chemicals results in the induction of expression of diverse genes and production of a broad spectrum of biological and toxic effects. The AhR also plays important roles in several physiological responses, which has led it to become a novel target for the development of therapeutic drugs. Differences in the interactions of various ligands within the AhR ligand binding domain (LBD) may contribute to differential modulation of AhR functionality. We combined computational and experimental analyses to investigate the binding modes of a group of chemicals representative of major classes of AhR ligands. On the basis of a novel computational approach for molecular docking to the homology model of the AhR LBD that includes the receptor flexibility, we predicted specific residues within the AhR binding cavity that play a critical role in binding of three distinct groups of chemicals. The prediction was validated by site-directed mutagenesis and evaluation of the relative ligand binding affinities for the mutant AhRs. These results provide an avenue for understanding ligand modulation of the AhR functionality and for rational drug design.

Overview

CoChat Summary

## TL;DR

This paper combines ensemble molecular docking, molecular dynamics, MM-GBSA, and mutagenesis to explain how diverse Ah receptor (AhR) ligands bind in different ways within the mouse AhR ligand-binding domain. The authors classify 10 agonists into three binding groups and validate several predicted residue–ligand interactions experimentally.

## Key findings

  • All 10 test ligands competed with \[3H\]TCDD for binding to mouse AhR and stimulated AhR transformation/DNA binding.
  • Relative binding affinities (IC50) ranged from 1 nM for TCDD and FICZ to 2190 nM for LEFL; relative potencies to stimulate DNA binding (EC50) ranged from 4 nM for DBA to 26,800 nM for LEFL.
  • The ligands fell into three binding groups:
  • Group 1: TCDD, TCDF, BaP bind at the bottom of the cavity and are stabilized mainly by hydrophobic interactions, especially with L302 and L309.
  • Group 2: 3MC, PCB126, DBA bind nearer the Fα/Gβ site with hydrophobic stabilization, involving M334 and M342.
  • Group 3: BNF, FICZ, IR, LEFL also bind near the Fα/Gβ site, but are additionally stabilized by polar interactions/H-bonds with C327, S330, S359, Q377.
  • Mutagenesis supported many predictions: L302A eliminated ligand-stimulated DNA binding, L309A strongly reduced binding, and other substitutions changed ligand affinities in ligand-specific ways (for example, P291L increased TCDF affinity from 20 nM to 0.04 nM).

## Methods

  • The study combined computational and experimental approaches using 10 representative AhR ligands from several chemical classes.
  • Computational work used 11 homology models of the mouse AhR LBD built from different HIF-2α PAS-B templates, followed by ensemble docking, molecular dynamics simulations (10 or 20 ns production runs), and MM-GBSA binding free-energy calculations.
  • Experimental validation used site-directed mutagenesis of mouse AhR plus \[3H\]TCDD competitive binding assays and gel retardation DNA-binding assays; mutant effects were quantified by IC50 and EC50 estimates.

## Limitations

  • The paper states that quantitative prediction of binding free energy was beyond the aim of the work, and computed energies showed only a weak trend with experiment (Pearson R² = 0.37; Spearman ρ = 0.64).
  • The authors note that some modeled AhR conformations did not completely describe binding-site flexibility, and that this may have prevented some ligands from reaching the bottom of the cavity.
  • Evidence evident from the text: the work relies on homology models rather than an experimentally determined AhR LBD structure, so conclusions about poses are model-dependent.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41598-019-47138-z

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 2D representation of the set of ligands analyzed in this study and the homology models of the mouse AhR (mAhR) PAS-B domain developed here. (a) Structures of AhR ligands used in this study. (b) Cartoon representation of all the mAhR PAS-B models superimposed. The region refined by loop modeling is colored according to the model. Secondary structure elements are labeled according to the PAS domain nomenclature73.
Figure 1 2D representation of the set of ligands analyzed in this study and the homology models of the mouse AhR (mAhR) PAS-B domain developed here. (a) Structures of AhR ligands used in this study. (b) Cartoon representation of all the mAhR PAS-B models superimposed. The region refined by loop modeling is colored according to the model. Secondary structure elements are labeled according to the PAS domain nomenclature73.CC BY · PubMed Central
Figure 2 Correlation between the relative affinity of each test compound to bind to the mAhR and their relative potency to stimulate AhR DNA binding (Pearson correlation coefficient R2 = 0.56). The relative affinity (LogIC50) and potency (LogEC50) of the indicated test compounds was determined by [3H]TCDD competitive ligand binding and ligand-dependent DNA binding analysis as described under Materials and Methods.
Figure 2 Correlation between the relative affinity of each test compound to bind to the mAhR and their relative potency to stimulate AhR DNA binding (Pearson correlation coefficient R2 = 0.56). The relative affinity (LogIC50) and potency (LogEC50) of the indicated test compounds was determined by [3H]TCDD competitive ligand binding and ligand-dependent DNA binding analysis as described under Materials and Methods.CC BY · PubMed Central
Figure 3 Internal surfaces of the binding cavities for the HIF-2α templates (gray and transparent with the ligand inside) and for the mAhR models (colored and solid). Models are ordered by increasing cavity volumes (Table S3).
Figure 3 Internal surfaces of the binding cavities for the HIF-2α templates (gray and transparent with the ligand inside) and for the mAhR models (colored and solid). Models are ordered by increasing cavity volumes (Table S3).CC BY · PubMed Central
Figure 4 Dynamic view of a TCDD pose inside the binding cavity; ligand is shown as sticks and protein as gray cartoons. In blue, the pose previously obtained by docking24; in dark green, one of the docking poses obtained in this work; in green, 10 snapshots taken from the last 8 ns of the MD simulation.
Figure 4 Dynamic view of a TCDD pose inside the binding cavity; ligand is shown as sticks and protein as gray cartoons. In blue, the pose previously obtained by docking24; in dark green, one of the docking poses obtained in this work; in green, 10 snapshots taken from the last 8 ns of the MD simulation.CC BY · PubMed Central
Figure 5 Ligands are gathered into three groups that were defined by the occupancy of different sites inside the AhR cavity and by characteristic residue interactions during MD simulations. (a) Per-residue decomposition of ΔGbind. Values were obtained as averages of the last 8 ns of simulation. In the plots, only residues lining the internal cavity are shown. (b) Ten snapshots sampled during the last 8 ns of simulation are shown for each ligand belonging to the three groups; ligands are represented as sticks.
Figure 5 Ligands are gathered into three groups that were defined by the occupancy of different sites inside the AhR cavity and by characteristic residue interactions during MD simulations. (a) Per-residue decomposition of ΔGbind. Values were obtained as averages of the last 8 ns of simulation. In the plots, only residues lining the internal cavity are shown. (b) Ten snapshots sampled during the last 8 ns of simulation are shown for each ligand belonging to the three groups; ligands are represented as sticks.CC BY · PubMed Central
Figure 6 Dynamic view of the binding poses of ligands in group 1, (a) TCDD, (b) TCDF, (c) BaP and group 2, (d) 3MC, (e) PCB126, (f) DBA. Ligands are represented as sticks and 10 snapshots extracted during the last 8 ns of MD simulation are shown in transparency; solid sticks indicate the most sampled poses in the MD simulations. The most relevant residues identified by per-residue decomposition of ΔGbind are shown as lines and labeled.
Figure 6 Dynamic view of the binding poses of ligands in group 1, (a) TCDD, (b) TCDF, (c) BaP and group 2, (d) 3MC, (e) PCB126, (f) DBA. Ligands are represented as sticks and 10 snapshots extracted during the last 8 ns of MD simulation are shown in transparency; solid sticks indicate the most sampled poses in the MD simulations. The most relevant residues identified by per-residue decomposition of ΔGbind are shown as lines and labeled.CC BY · PubMed Central
Figure 7 Dynamic view of the binding poses of ligands in group 3: (a) BNF, (b) FICZ, (c) IR, and (d) LEFL. Ligands are represented as sticks and 10 snapshots extracted during the last 8 ns of the MD simulation are shown in transparency; solid sticks are the most sampled poses in the MD simulations. The most relevant residues identified by per-residue decomposition of ΔGbind are shown as lines and labeled.
Figure 7 Dynamic view of the binding poses of ligands in group 3: (a) BNF, (b) FICZ, (c) IR, and (d) LEFL. Ligands are represented as sticks and 10 snapshots extracted during the last 8 ns of the MD simulation are shown in transparency; solid sticks are the most sampled poses in the MD simulations. The most relevant residues identified by per-residue decomposition of ΔGbind are shown as lines and labeled.CC BY · PubMed Central
Figure 8 Relative binding affinity for group 1, 2 and 3 ligands relative to wild-type and mutant AhRs. The relative affinity (−logIC50) of each test chemical for the AhR ligand was determined from concentration-dependent inhibition curves obtained using [3H]TCDD ligand binding analysis, as described under Materials and Methods. The mean IC50 ± standard deviation was determined using three-parameter non-linear regression of nine independent reactions. (*) Represents a significant (p ≤ 0.05) change in ligand binding affinity relative to wild-type mAhR in One-Way ANOVA Multiple Comparison Test.
Figure 8 Relative binding affinity for group 1, 2 and 3 ligands relative to wild-type and mutant AhRs. The relative affinity (−logIC50) of each test chemical for the AhR ligand was determined from concentration-dependent inhibition curves obtained using [3H]TCDD ligand binding analysis, as described under Materials and Methods. The mean IC50 ± standard deviation was determined using three-parameter non-linear regression of nine independent reactions. (*) Represents a significant (p ≤ 0.05) change in ligand binding affinity relative to wild-type mAhR in One-Way ANOVA Multiple Comparison Test.CC BY · PubMed Central

Verification

Claims the paper makes

16 Valid · 2 Not valid · 2 Not checked · 95 Own results and interpretations

57 more claims · 1 with their cited sources checked

Create a free account to see all 115 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 49
  • Probably not a substantial claim. 5
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 73 references

Research works printed but not linked: 1

  1. Denison, M. S. et al. Natural and synthetic ligands for the Ah receptor. in Molecular Biology of the Toxic Response (eds Puga, A. & Wallace, K.) 393–410 (Taylor & Francis, 1998).

Cited by

See all 106

Metadata

Authors
Giani Tagliabue, S., Faber, S. C., Motta, S., Denison, M. S., & Bonati, L.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • University of Milano-Bicocca (IT)
  • University of California, Davis (US)
Corresponding author
Bonati, Laura
Venue
Scientific Reports
Published
2019-07-23
Volume
9
Issue
1
Pages
10693-10693
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2963940223
Cited by
106
References
73
Citations by year
2026: 10 · 2025: 14 · 2024: 14 · 2023: 16 · 2022: 16 · 2021: 14 · 2020: 19 · 2019: 3
FWCI
9.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (R01ES007685, T32ES007059)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
Keywords
Ah receptor, ligand-binding domain, ligand binding modes, receptor flexibility, homology modeling, site-directed mutagenesis, binding affinity, transcription factor activation, rational drug design, environmental chemicals
MeSH terms
Binding Sites, Humans, Ligands, Models, Molecular, Protein Binding, Receptors, Aryl Hydrocarbon, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling the binding of diverse ligands within the Ah receptor ligand binding domain. https://app.cochat.ai/papers/10.1038/s41598-019-47138-z
The paper
Giani Tagliabue, S., Faber, S. C., Motta, S., Denison, M. S., & Bonati, L. (2019). Modeling the binding of diverse ligands within the Ah receptor ligand binding domain. Scientific Reports. https://doi.org/10.1038/s41598-019-47138-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.